Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jul 2021 for Oncotelic Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Saran Saund: trading record in brief
This profile gathers the share dealings of Saran Saund in Oncotelic Therapeutics, Inc. We count 2 filings; the first trade dates from 31 March 2021 and the latest from 8 July 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 July 2021: a share grant, in Oncotelic Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Saran Saund
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
16,354,961 sharesCommon StockSEC:0001493152-21-017102:0
1 of 1 declaration
